NDAORALCAPSULEPriority Review
Approved
Apr 2022
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Breast Cancer Resistance Protein Inhibitors
Pharmacologic Class:
Azole Antifungal
Loss of Exclusivity
LOE Date
Mar 17, 2036
122 months away
Patent Expiry
Mar 17, 2036
Exclusivity Expiry
Apr 26, 2032